STAT3 and multiple sclerosis: Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) agonists inhibit Th17 differentiation in isolated T cells derived from multiple sclerosis and healthy patients by blocking STAT3 and downregulating RORγt, with a subsequent decrease in IL-17A protein production [269].